Effect of Academic Detailing to Reduce Opioid Prescribing in Dentistry

Sponsor
University of Michigan (Other)
Overall Status
Completed
CT.gov ID
NCT04425668
Collaborator
Michigan Department of Health and Human Services (Other)
63
1
2
13
4.9

Study Details

Study Description

Brief Summary

The purpose of this project is to improve quality of care for dental patients in the state of Michigan. This will be achieved through educating dentists about best practices for opioid prescribing and includes three continuing education (CE) credits and one (or two) academic detailing (AD) visits. The cohort of 90 dentists who are enrolled to the CE will be randomized into two groups upon enrollment. One of these groups, half of the cohort, will receive the academic detailing. A report will be written highlighting key findings from this project and best practices for treating patients after dental care.The quality of care for dental patients will be improved by sharing this information with both participating and non-participating dental providers statewide through reports, manuscripts, and presentations. These data will inform best practice with the potential for future academic detailing and educational interventions for dentists and oral surgeons.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Academic detailing (AD)
  • Other: Continuing educational
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
63 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Masking Description:
Single blinded- dentists to be blinded; Analyses will be done by blinded analyst
Primary Purpose:
Other
Official Title:
Effect of Academic Detailing to Reduce Opioid Prescribing in Dentistry: a Randomized Quality Improvement Effort
Actual Study Start Date :
Apr 29, 2020
Actual Primary Completion Date :
May 29, 2021
Actual Study Completion Date :
May 29, 2021

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Control Group

Other: Continuing educational
Dentists enrolled in the CE program will serve as the control group. They will have access to the 3 hours of CE content online similar to the AD group; however, they will not receive academic detailing or the opportunity to connect via phone with Dr. Nalliah. In this group, if the dentists have content-specific questions after participating in the CE program, they may contact MichiganOPENdental@umich.edu for responses appropriately directed to Dr. Nalliah.

Experimental: Academic detailing intervention

Behavioral: Academic detailing (AD)
In addition to continuing educational (CE) videos this group will receive up to two personalized, one-on-one, education sessions from an academic detailer. The sessions will last between 15-30 minutes. Each AD visit will consist of: an introduction, a brief needs assessment, key educational messages, a discussion of challenges the provider faces, and giving the provider leave-behind educational materials. The AD visit key educational messages are specific recommendations for opioid-prescribing practice change. When appropriate the detailer will suggest a phone call with Dr. Romesh Nalliah to discuss specific dentistry questions. There may also be a second AD visit if agreed upon by the dentist.

Outcome Measures

Primary Outcome Measures

  1. Change in the amount of opioid prescribed measured in the total oral morphine equivalents [baseline, up to 3 months]

    Opioid data from the Michigan Automated Prescription Service (MAPS), state prescription drug monitoring program (PDMP) will be used. These periods yield 63 working weekdays in each period.

Secondary Outcome Measures

  1. Change in the number of opioid prescriptions [baseline, up to 3 months]

    Number of opioid prescription details through PDMP data pulled from MAPS.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Dentists in the state of Michigan with an active drug enforcement agency (DEA) license.
Exclusion Criteria:
  • All oral Surgeons in Michigan. Michigan dentists who have a significant (>5%) population living outside of Michigan (self-reported), as the prescription drug monitoring program (PDMP) data we will obtain from Michigan Automated Prescription Service (MAPS) will only cover those prescriptions filled in the state of Michigan.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Chad Brummett Ann Arbor Michigan United States 48104

Sponsors and Collaborators

  • University of Michigan
  • Michigan Department of Health and Human Services

Investigators

  • Principal Investigator: Chad Brummett, M.D., University of Michigan

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Chad Brummett, Professor of Anesthesiology Research, Senior Associate Chair for Research, University of Michigan
ClinicalTrials.gov Identifier:
NCT04425668
Other Study ID Numbers:
  • HUM00175142
First Posted:
Jun 11, 2020
Last Update Posted:
Jun 2, 2021
Last Verified:
May 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Chad Brummett, Professor of Anesthesiology Research, Senior Associate Chair for Research, University of Michigan

Study Results

No Results Posted as of Jun 2, 2021